Generative AI is poised to transform biopharma regulatory affairs by automating content creation and data analysis, promising significant gains in submission speed, productivity, and quality. Successful adoption requires addressing challenges like potential inaccuracies and user hesitation through strong data governance, domain expertise, and comprehensive change management.